Abiopharma

News list

Kiener Peter A 🟢 acquired 24.4K shares (1 derivative) of Cue Biopharma, Inc. (CUE) at $0.34 Transaction Date: Jan 02, 2026 | Filing ID: 004359

Full text

News bot Jan. 6, 2026, 9:04 p.m.
🔍 Kiener Peter A (Executive)

Company: Cue Biopharma, Inc. (CUE)

Report Date: 2026-01-02
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 24,400
Detailed Transactions and Holdings:
- Acquired 24,400 shares of Stock Option (right to buy) at $0.34 per share (Derivative)
  Date: 2026-01-02 | Code: A | Expires: 2036-01-01 | equity_swap_involved: false | shares_owned_after: 24,400.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy.
- F2: This stock option becomes fully exercisable on the first anniversary of the grant date.